Furosemide is not indicated for the treatment of Wolff-Parkinson-White (WPW) syndrome.
Furosemide indications
- Furosemide is primarily used for the treatment of edema in adults, including edema associated with congestive heart failure and renal failure, as well as for the management of hypertension
- It is also used off-label for the treatment of ascites in adults with liver cirrhosis and hypercalcemia
WPW syndrome management
- The management of WPW syndrome may involve observation, especially in asymptomatic patients with pre-excitation and a low-risk accessory pathway
- Catheter ablation is recommended in high-risk asymptomatic patients with pre-excitation and may be considered in low-risk asymptomatic patients with pre-excitation at appropriately experienced centers
- Certain medications, such as sumatriptan and zolmitriptan, are contraindicated in patients with WPW syndrome due to the presence of accessory conduction pathway disorders
In conclusion, furosemide is not effective in the management of WPW syndrome, as it is not indicated for this condition. The management of WPW syndrome typically involves observation or catheter ablation, depending on the patient's risk profile and symptoms. Certain medications are contraindicated in this condition due to the presence of accessory conduction pathways.